faCellitate is a life science tools company targeting customers in drug discovery, toxicology, industrial biotech and stem cell research.
faCellitate develops polymeric platforms that aim at supporting cancer and stem cell research, drug discovery, toxicology, and tissue engineering. The platform facilitates cellular interaction, significantly improving cell culture in biological research.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 7, 2022 | Seed | €3.70M | 6 | High-Tech Grunderfonds SARSTEDT | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
High-Tech Grunderfonds | Yes | Seed |
SARSTEDT | Yes | Seed |
ARVE Capital | — | Seed |
Chemovator | — | Seed |
R3 | — | Seed |
ROI land investment | — | Seed |